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Abstract
Drug abuse is a contributing factor in women’s HIV risk in low-income communities in Cape 
Town, South Africa. This study assessed whether experiencing violence is associated with reduced 
drug abstinence among adult women (n = 603) participating in a randomized field trial for an HIV 
prevention study in Cape Town. In relation to drug abstinence at 12-month follow-up, 
multivariable regression models were used to assess (1) baseline partner and non-partner 
victimization, and (2) victimization at 12-month follow-up among participants reporting baseline 
victimization. Baseline partner (AOR = 0.6; 95 % CI 0.4–0.9) and non-partner victimization (AOR 
= 0.6; 95 % CI 0.4–0.9) were associated with a reduced likelihood of drug abstinence at follow-up. 
Among participants who reported victimization at baseline, those no longer reporting 
victimization at follow-up did not differ significantly in drug abstinence compared with those who 
reported victimization at follow-up. The study findings highlight the lasting impact of 
victimization on women’s drug use outcomes, persisting regardless of whether violence was no 
longer reported at follow-up. Overall, the findings support the need for the primary prevention of 
violence to address the cycle of violence, drug use, and HIV among women in this setting.
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Introduction
Illicit drug use is a major public health problem in the Western Cape Province of South 
Africa [1–3]. Drug use among poor South African women has been consistently associated 
with sex risk behaviors for HIV, including exchanging sex for drugs or money and 
inconsistent condom use [4–9]. Consequently, promoting abstinence from drug use has been 
proposed as one strategy for preventing HIV among vulnerable drug-using women [10].
Among South African women using drugs, however, the ability to achieve and maintain 
abstinence from drug use may be hampered by their experiences of gender-based violence 
(physical and/or sexual violence perpetrated by males who are often relationship partners). 
Gender-based violence is commonplace in South Africa, with studies reporting that between 
one in four and one in two women have lifetime histories of violence exposure [11–13]. 
Experiences of violence not only place South African women at increased risk for HIV 
infection [11, 14–17] but they are also a major contributing factor to women’s drug use [18–
20]. For women with these experiences, drug use may serve as a coping mechanism for the 
psychological outcomes of violence, such as trauma [20–22]. Additionally, the prevalence of 
drug use among male perpetrators of gender-based violence is high, and drug use is 
associated with increased risk of violence perpetration [23–29]. Consequently, women in 
relationships characterized by gender-based violence are more likely to be exposed to drug 
use through their male partner, which may make it more difficult for women to quit using 
drugs [30].
While the intersection between violence and drug use appears to be critical to informing 
HIV prevention efforts among women, currently our understanding of these issues is 
limited. The few studies that have examined whether experiences of partner violence inhibit 
women’s ability to stop using drugs support assertions that women with histories of partner 
victimization have poorer treatment outcomes than women without experiences of violence 
[31–34]. However, relatively little has been published on the effects of non-partner gender-
based violence on drug use outcomes [35]. Furthermore, no studies have examined whether 
programming efforts to reduce partner violence or non-partner victimization have a specific 
effect on women’s drug use outcomes. Consequently, the present study examines the 
following aims among women participants of a randomized HIV and drug prevention field 
trial: (1) to describe the relation between women’s reports of victimization at baseline and 
drug abstinence at follow-up; and (2) to examine whether decreases in partner and non-
partner victimization between intervention assessment periods are associated with women’s 
drug use outcomes.
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Study Design, Recruitment and Enrollment Procedures
A randomized HIV prevention field trial was conducted among low-income communities in 
Cape Town between September 2008 and January 2012. The study methods have been 
described in detail elsewhere [35]. A total of 720 women were recruited to participate in the 
study, and the 603 women who completed the follow-up assessments were included in the 
current analyses. Eligible women were of childbearing age (18–33 years old), lived in one of 
the targeted communities (e.g., low income, disadvantaged), reported using at least two 
drugs (one of which could be alcohol) at least once a week for the past 3 months, reported 
being sexually active in the past month, and had not participated in the pilot study [36].
A rigorous sampling plan was developed to ensure a balanced recruitment of women across 
all the targeted communities. Peer outreach workers recruited participants via the 
distribution of marketing materials in areas frequented by potential participants, such as 
beauty parlors and convenience stores. Outreach workers approached potential participants 
and requested verbal permission to administer a brief screener to assess eligibility. If 
eligible, women who were interested in the study were scheduled for an intake interview 
where they were rescreened and enrolled in the study after giving informed consent. After 
enrollment, participants completed a baseline interview, provided urine specimens for drug 
testing, completed alcohol breathalyzer testing, and received HIV counselling and testing 
(HCT).
Randomization, Intervention Conditions and Follow-Up Interviews
Following the baseline interview, participants were randomized by computer to one of three 
intervention conditions: 50 % were randomized to the Women’s Health CoOp (WHC), the 
experimental intervention that addresses alcohol and other drug use risks, sexual risks for 
HIV, violence, and gender inequality; 25 % to the Nutrition (equal-attention) comparison 
group that teaches principles of healthy eating and food preparation; and 25 % to an HCT-
only control group. Both the WHC and Nutrition intervention conditions were delivered in a 
group-based format to foster social support of women. More detailed information regarding 
the specific curriculum of the various intervention conditions is provided elsewhere [35, 37, 
38].
After receiving the interventions, participants completed 3-, 6-, 9-, and 12-month follow-up 
assessments. Biological testing was conducted at the 6- and 12-month follow-up 
appointments only. Ethical approval for the study was granted by the Institutional Review 
Boards at RTI International and Stellenbosch University’s Faculty of Health Sciences.
Measures
Demographic variables included age, race/ethnicity (Black African, Coloured [people of 
mixed race ancestry who form a particular ethnic and cultural grouping in South Africa]), 
employment (any employment, no employment), educational attainment (11th grade or less, 
12th grade or greater), and homelessness.
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The primary outcome was biologically confirmed abstinence from drug use at 12 months. 
Participants gave a urine specimen that was tested using the four-panel Reditest drug test 
(Redwood Toxicology Laboratory) for methamphetamine, cocaine, opiates, and THC 
(marijuana); recent alcohol use was tested with a breathalyzer. Urine was also tested for 
Mandrax (methaqualone) by a drug testing laboratory using standard gas chromatography 
techniques. Participants were classified as abstinent if they tested negative for all drugs and 
not abstinent if they tested positive for one or more drugs.
A dichotomous variable was created to reflect any intimate partner violence (IPV) in the 
past 6 months. Women who reported any physical violence (being slapped, pushed, shoved, 
kicked, hit with a fist or something else; dragged; beaten, choked; or burned) or sexual 
violence (forced vaginal, oral, or anal sex) by an intimate partner were categorized as having 
prior experiences of IPV. An additional dichotomous variable was constructed to reflect 
“decreased IPV” between baseline and follow-up. For this variable, participants who 
reported IPV at baseline with no IPV at 12-month follow-up were categorized as having 
decreased exposure to IPV.
In addition, a dichotomous variable (i.e., “prior exposure to non-partner victimization”) was 
constructed to reflect any physical or sexual victimization by someone other than their main 
relationship partner in the past 6 months. Non-partner physical victimization included 
reports of having been beaten up, having been cut by a knife, having been shot at, or having 
been threatened with a weapon in the past 6 months. Non-partner sexual victimization 
included reports of being forced to have sex, being forced to have sex with more than one 
person at a time, or being gang raped. To assess decreases in non-partner victimization 
between baseline and follow-up, a dichotomous variable was constructed, “decreased non-
partner victimization.” Participants who reported non-partner victimization at baseline but 
no non-partner victimization at 12-month follow-up were classified as having decreased 
non-partner victimization.
Data Analysis
Initially, interactions by intervention condition (experimental, comparison, and control 
groups) were examined to understand differential effects of violence on drug abstinence 
using generalized linear mixed models, with repeated measures at baseline, 6, and 12 
months. Time was coded as a categorical measure with an unstructured covariance error 
structure, as preliminary analyses revealed that alternative specifications of the functional 
form (e.g., linear) of time and covariance structure (e.g., autoregressive) were not 
appropriate for these data. There were no significant interaction effects of violence by 
intervention arm, with all groups demonstrating significant changes in abstinence from 
baseline to 12-month follow-up. The WHC experimental condition had the greatest 
increases in drug use abstinence; however there were no statistically significant differences 
in decreased victimization reported by intervention condition. Given that there were no 
significant interaction effects by condition, these groups were combined in the models 
examining the relation between victimization and drug use outcomes (with intervention 
condition included as a covariate). Crude (adjusted for intervention condition only) and then 
adjusted (adjusted for condition and relevant demographic variables) logistic regression 
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models were used to examine drug abstinence at 12-month follow-up in relation to (1) 
baseline experiences of IPV (past 6 months), (2) baseline reports of non-partner 
victimization (past 6 months), and (3) victimization no longer reported at 12-month follow-
up among those reporting baseline victimization. All demographic variables were examined 
in relation to drug use abstinence and those that were statistically significantly associated (p 
< 0.05) with drug abstinence were included in adjusted regression analyses. All analyses 
were conducted using SAS version 9.1 (SAS Institute Inc, Cary, North Carolina).
Results
Sample Characteristics
The mean age of the sample (n = 603) was 23 (standard deviation = 1.8 years). Just under 
half of the sample (43 %) identified as Black African; the remaining 57 % identified as 
Coloured. Most (90 %) participants were unemployed, 2 % were homeless, and 89 % had an 
11th-grade education or less. Only 19 % of participants with an 11th-grade education or less 
were abstinent at 12-month follow-up, compared with 33 % of participants with at least a 
12th-grade education (χ2 = 6.5, p < 0.01). Black African participants were most likely to 
report drug abstinence at follow-up, with 33 % reporting abstinence, compared with only 11 
% of Coloured participants (χ2 = 42.5, p < 0.0001). Other demographic variables were not 
significantly associated with drug abstinence at 12-month follow-up and are not shown.
At baseline, just over half (51 %) of participants reported prior experiences of non-partner 
victimization; 49 % of the sample reported non-partner physical victimization and 8 % 
reported non-partner sexual victimization. Approximately one third (33.3 %) reported IPV 
exposure in the 6 months prior to baseline assessment.
Association Between Exposure to IPV, Non-partner Victimization, and Drug Abstinence
The logistic regression model findings indicate that recent IPV exposure (odds ratio [OR] = 
0.5; 95 % confidence interval [CI] 0.3–0.7), and exposure to non-partner victimization (OR 
= 0.4; 95 % CI 0.3–0.6) were associated with decreased likelihood of abstinence from drug 
use at follow-up (Table 1). After adjusting for the influence of race/ethnicity and education 
on abstinence, these associations remained significant. Participants exposed to IPV (adjusted 
odds ratio [AOR] = 0.6; 95 % CI 0.4–0.9) or non-partner victimization (AOR = 0.6; 95 % CI 
0.4–0.9) had a 40 % decreased likelihood of abstinence from drug use at follow-up 
compared with participants without exposure to these forms of violence.
Among participants who reported victimization at baseline, those no longer reporting 
victimization at follow-up did not differ significantly in drug abstinence compared with 
participants who continued to report victimization at follow-up. Models adjusting for the 
influence of race/ethnicity and education on abstinence produced similar findings.
Discussion
Overall, the findings suggest that experiencing non-partner or partner victimization impedes 
women’s ability to achieve abstinence from drug use within the context of an integrated 
drug and HIV risk-reduction program. These findings extend those of earlier studies that 
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documented the effects of IPV on increasing women’s drug use, and build on the few 
existing studies that documented the negative effect of victimization on drug intervention 
outcomes among women [32–34] Specifically, we found that even after controlling for other 
factors associated with drug use abstinence, experiencing IPV or non-partner victimization 
was associated with a 40 % decreased likelihood of achieving abstinence. The deleterious 
effects of victimization on drug abstinence is also a particular concern given that continuing 
drug use among women participating in an HIV risk-reduction program is likely to impact 
negatively on HIV prevention goals. Consequently, the findings underscore the intersection 
of gender-based violence and drug use in increasing women’s risk for HIV, which can 
potentially impede ongoing HIV prevention efforts among women, particularly in contexts 
where drug use is widespread.
In addition, the findings indicate that not only does previous victimization (reported at 
baseline as occurring within the past 6 months) affect women’s drug use outcomes at 12-
month follow-up, but prior victimization also continues to affect women’s drug outcomes, 
even when there is no additional exposure to victimization. Given these lasting effects when 
violence is no longer reported, the findings suggest that time needed for healing and coping 
with experiences of violence may partly explain the association between victimization and 
reduced drug abstinence observed during this study. While women may have greater 
exposure to or access to drugs in contexts where violence is occurring (e.g., from abusive 
male partners), we did not find that drug abstinence was improved when reductions in 
violence were reported and the findings do not support this as a mechanism for explaining 
the observed associations. More work is needed however, to better understand these and 
other possible mechanisms underpinning the study findings.
While studies have shown the benefits (in terms of drug use outcomes) of helping women 
heal from their experiences of trauma within the context of drug treatment programs for 
women with histories of abuse [33, 34], the current study suggests that compared with 
women who do not have experiences of victimization, those with such experiences fare 
worse in terms of drug abstinence outcomes. Consequently, efforts to help women heal from 
experiences of victimization, while essential, may take longer to have a measurable impact 
on drug use. Efforts are needed to identify other ways to help women reduce the impact of 
victimization on their drug use, such as identifying mechanisms other than drug use that will 
help women cope with victimization experiences.
Most notably, the findings suggest that more efforts are needed to prevent victimization 
experiences among women, such as focusing on the primary prevention of violence against 
women. These efforts likely need to engage the larger community (including men) to 
address the structural, gender-based, and social factors that are the primary determinants of 
violence in this context [39–41]. For example, previous work in South Africa has used 
community mobilization strategies effectively to engage the community on issues of the 
prevention of violence against women [39–41]. Similar strategies may be useful to address 
violence in contexts where drug use intersects with violence in determining women’s HIV 
risk. Drawing from this previous work using structural approaches for the prevention of 
violence and HIV risk among women, more work is needed to examine ways of engaging 
both men and women at the community level to prevent violence against women.
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The current study has several limitations that may have affected the findings. First, reliance 
on self-reported experiences of violence may have resulted in the underreporting of 
women’s experiences of victimization; however, the prevalence of violence was very high 
nonetheless. Second, as this study examined experiences of violence in the previous 6 
months, more work is needed to understand the effects of victimization across the life-
course, and particularly the effects of early life experiences of victimization, on drug use 
outcomes. Third, the parent study was not powered to detect the effect of the intervention on 
HIV incidence; consequently more work is needed to understand the impact of violence on 
not only drug abstinence but also on drug and sex risk behaviors as well as HIV incidence.
These limitations notwithstanding, the current study documents the high prevalence of 
victimization reported by women and that such violence is perpetrated by both male partners 
and non-partners. Furthermore, the findings highlight how experiences of violence 
negatively impact drug use outcomes among women in our study population. Specifically, 
experiences of violence have a powerful and lasting influence on women’s drug use 
outcomes. This observed impact suggests that broader community-level efforts, such as 
addressing structural and social determinants of violence, to prevent initial and recurrent 
victimization are essential for maximizing drug abstinence. Together, community-level 
efforts to prevent women’s experiences of violence and women-centered programs that 
support women on issues of victimization—particularly to reduce the impact of 
victimization on women’s drug use—may be critical to address the cycle of violence, drug 
use, and HIV among women in communities with high HIV prevalence in Cape Town.
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Table 1







(n = 126) % (n)
No drug abstinence
at follow-up







Intimate partner violence victimization
 Yes 33.3 (201) 21.4 (27) 36.5 (174) 0.5 (0.3–0.7)⊨ 0.6 (0.4–0.9)†
 No 66.7 (402) 78.6 (99) 63.5 (303) 1.0 Referent 1.0 Referent
Non-partner physical or sexual victimization
 Yes 50.9 (307) 35.7 (45) 54.9 (262) 0.4 (0.3–0.6)╬ 0.6 (0.4–0.9)†
 No 49.1 (296) 64.3 (81) 45.1 (215) 1.0 Referent 1.0 Referent
Changes in victimization between
 baseline and follow-up
Reporting intimate partner violence
 at baseline
(n = 201) % (n) (n = 27) % (n) (n = 174) % (n)
No intimate partner violence victimization
 at follow-up
 Yes 72.6 (146) 77.8 (21) 71.8 (125) 1.4 (0.5–3.6) 1.2 (0.4–3.3)
 No 27.4 (55) 22.2 (6) 28.2 (49) 1.0 Referent 1.0 Referent
Reporting non-partner physical or sexual
 victimization at baseline
(n = 307) % (n) (n = 45) % (n) (n = 262) % (n)
No non-partner physical or sexual
 victimization at follow-up
 Yes 63.2 (194) 68.9 (31) 62.2 (163) 1.4 (0.7–2.7) 1.3 (0.6–2.7)
 No 36.8 (113) 31.1 (14) 37.8 (99) 1.0 Referent 1.0 Referent
^
Crude models are adjusted for treatment group
*
Adjusted models include treatment group, race/ethnicity, and education
†
p < 0.05, Wald;
⊨
p < 0.01, Wald;
╬
p < 0.0001, Wald
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